Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Antimicrob Agents Chemother. 2013 Nov;57(11):5729-32. doi: 10.1128/AAC.01038-13. Epub 2013 Aug 26.
Inactivation of acetyl-coenzyme A (acetyl-CoA) carboxylase confers resistance to fatty acid synthesis inhibitors in Staphylococcus aureus on media supplemented with fatty acids. The addition of anteiso-fatty acids (1 mM) plus lipoic acid supports normal growth of ΔaccD strains, but supplementation with mammalian fatty acids was less efficient. Mice infected with strain RN6930 developed bacteremia, but bacteria were not detected in mice infected with its ΔaccD derivative. S. aureus bacteria lacking acetyl-CoA carboxylase can be propagated in vitro but were unable to proliferate in mice, suggesting that the acquisition of inactivating mutations in this enzyme is not a mechanism for the evasion of fatty acid synthesis inhibitors.
在补充脂肪酸的培养基中,乙酰辅酶 A(acetyl-CoA)羧化酶的失活使金黄色葡萄球菌对脂肪酸合成抑制剂产生抗性。添加支链脂肪酸(1mM)加硫辛酸支持ΔaccD 菌株的正常生长,但补充哺乳动物脂肪酸的效率较低。感染 RN6930 菌株的小鼠发生菌血症,但感染其ΔaccD 衍生物的小鼠未检测到细菌。缺乏乙酰辅酶 A 羧化酶的金黄色葡萄球菌可以在体外繁殖,但不能在小鼠中增殖,这表明该酶的失活突变的获得不是逃避脂肪酸合成抑制剂的机制。